Sakar Healthcare Limited (NSE:SAKAR)
292.00
+22.95 (8.53%)
May 9, 2025, 3:30 PM IST
Sakar Healthcare Revenue
Sakar Healthcare had revenue of 434.17M INR in the quarter ending December 31, 2024, with 16.63% growth. This brings the company's revenue in the last twelve months to 1.71B, up 12.81% year-over-year. In the fiscal year ending March 31, 2024, Sakar Healthcare had annual revenue of 1.54B with 14.89% growth.
Revenue (ttm)
1.71B
Revenue Growth
+12.81%
P/S Ratio
3.69
Revenue / Employee
5.27M
Employees
325
Market Cap
6.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1.54B | 199.75M | 14.89% |
Mar 31, 2023 | 1.34B | 50.74M | 3.93% |
Mar 31, 2022 | 1.29B | 338.06M | 35.47% |
Mar 31, 2021 | 953.12M | 113.97M | 13.58% |
Mar 31, 2020 | 839.14M | 151.04M | 21.95% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |